近期若羽臣(003010)发布2025年一季报，证券之星财报模型分析如下： 财务概况 若羽臣(003010)在2025年一季度实现了显著的业绩增长。根据最新发布的财报，公司营业总收入达到 5.74亿元，同比上升54.16%；归母净利润为2742.2万元，同比上升113.88%；扣非净利润为2520.26万 元，同比上升107.62%。 盈利能力 公司在盈利能力方面表现出色。毛利率为53.94%，同比增加了118.84%；净利率为4.78%，同比增加了 38.74%。每股收益为0.17元，同比增长了122.64%。 成本与费用 尽管收入和利润大幅增长，但公司的三费(销售费用、管理费用、财务费用)占比也显著上升。三费总计 2.79亿元，占总营收的比例为48.69%，同比增幅达143.44%。这表明公司在成本控制方面面临一定压 力。 资产与负债 截至报告期末，公司货币资金为7.62亿元，同比增加89.52%；有息负债为4.07亿元，同比增加 122.01%。有息资产负债率已达24.54%，建议关注公司债务状况。 应收账款 应收账款为1.34亿元，与去年同期基本持平，但应收账款与利润的比例达到了126.97%，建议关 ...

[Table_Title2] 若羽臣(003010) | [Table_DataInfo] 评级： | 增持 | 股票代码： | 003010 | | --- | --- | --- | --- | | 上次评级： | 增持 | 52 周最高价/最低价： | 54.0/10.03 | | 目标价格： | | 总市值(亿) | 84.31 | | 最新收盘价： | 51.4 | 自由流通市值(亿) | 62.16 | | | | 自由流通股数(百万) | 120.93 | 证券研究报告|公司点评报告 [Table_Date] 2025 年 04 月 25 日 [Table_Title] 自有品牌高增长，业绩持续释放 [Table_Summary] 事件概述： 公司发布 2024 年年报以及 2025 年一季报。2024 年公司实现总营业收入 17.66 亿元，同比增长 29.26%；利润 总额达到 1.28 亿元，同比增长 125.87%；实现归母净利润 1.06 亿元，同比增长 94.58%。2025 年一季度公司实 现总营业收入 5.74 亿元，同比增长 54.16%；利润总额达到 0.27 亿元，同比增长 ...

Investment Rating - The investment rating for the company is not explicitly stated in the provided documents, but the overall performance suggests a positive outlook based on significant revenue and profit growth [1]. Core Insights - The company reported a revenue of 1.766 billion yuan in 2024, representing a year-on-year increase of 29.26%, with a net profit of 106 million yuan, up 94.58% [1]. - In Q1 2025, the company achieved a revenue of 574 million yuan, a 54.16% increase year-on-year, and a net profit of 27 million yuan, up 113.88% [1]. - The company plans to distribute a cash dividend of 0.5 yuan per share and a stock dividend of 0.4 shares per share, with a total cash dividend amounting to 79 million yuan, resulting in a dividend payout ratio of 75.09% [1]. Summary by Sections Self-Owned Brand Performance - The self-owned brand business generated revenue of 500 million yuan in 2024, a 90.28% increase, accounting for 28.37% of total revenue [2]. - The brand "Zhanjia" achieved revenue of 484 million yuan in 2024, with a year-on-year growth of 90.09%, and saw significant sales growth across multiple channels [2]. - The brand "Feicui" launched in September 2024, generated 12 million yuan in revenue in 2024, and continued to grow rapidly in Q1 2025 [2]. Brand Management Business - The brand management business reported revenue of 501 million yuan in 2024, a substantial increase of 212.24% [3]. - The brand "Kangwang" saw a 283% increase in sales across all channels in 2024, with significant growth on platforms like Tmall and Douyin [3]. - Strategic partnerships with international brands were established to enhance the company's presence in the health and personal care sectors [4]. Gross Margin Improvement - The overall gross margin for the company improved to 44.57% in 2024, an increase of 4.33 percentage points year-on-year [4]. - The gross margin for the self-owned brand "Zhanjia" reached 66.92%, reflecting a 4.2 percentage point increase [4]. - In Q1 2025, the company's gross margin further increased to 53.94% [4].

Investment Rating - The investment rating for the company is not explicitly stated in the provided documents, but the overall performance suggests a positive outlook based on significant revenue and profit growth. Core Insights - The company reported a revenue of 1.766 billion yuan in 2024, representing a year-on-year increase of 29.26%, with a net profit of 106 million yuan, up 94.58% year-on-year. In Q1 2025, revenue reached 574 million yuan, a 54.16% increase, and net profit was 27 million yuan, up 113.88% year-on-year [1][2]. - The self-owned brand business showed remarkable performance, with revenue of 500 million yuan in 2024, a 90.28% increase, accounting for 28.37% of total revenue. The brand "Zhanjia" achieved a revenue of 484 million yuan, with a 90.09% increase, and significant growth in various sales channels [2][3]. - The brand management business also demonstrated strong growth, with revenue of 501 million yuan in 2024, a 212.24% increase. Notable brands like "Kangwang" and "Aiwei Nuo" saw substantial sales growth across multiple platforms [3][4]. - The overall gross margin for the company improved to 44.57% in 2024, an increase of 4.33 percentage points year-on-year, with specific margins for different business segments showing varied performance [4]. Summary by Sections Financial Performance - In 2024, the company achieved a total revenue of 1.766 billion yuan, with a net profit of 106 million yuan, and in Q1 2025, revenue was 574 million yuan with a net profit of 27 million yuan [1]. - The proposed dividend for 2024 is 0.5 yuan per share, with a total cash dividend of 79 million yuan, resulting in a dividend payout ratio of 75.09% [1]. Brand Performance - The self-owned brand "Zhanjia" launched a strategic product and achieved significant sales growth, ranking first in Tmall's new brand sales during the Double Eleven shopping festival [2]. - The brand "Feicui" also showed rapid sales growth since its launch, ranking highly on various e-commerce platforms [2]. Business Segments - The brand management segment reported a revenue increase of 212.24% in 2024, with notable contributions from brands like "Kangwang" and "Aiwei Nuo" [3]. - Strategic partnerships with international brands were established to enhance the company's presence in the health and personal care sectors [4].

Core Insights - The company, Ruoyuchen, reported significant revenue and profit growth for 2024 and Q1 2025, with 2024 revenue reaching 1.766 billion yuan, a 29.26% increase year-on-year, and net profit of 106 million yuan, up 94.58% [2] - In Q1 2025, the company achieved revenue of 574 million yuan, a 54.16% increase, and net profit of 27.42 million yuan, a 113.88% increase [2] Revenue Breakdown - The brand management business generated 501 million yuan in revenue for 2024, a remarkable 212.24% increase, accounting for 28.38% of total revenue [2] - The proprietary brand business also showed strong performance with 500 million yuan in revenue, a 90.28% increase, making up 28.37% of total revenue [2] - The agency operation business reported revenue of 764 million yuan, with a significant increase in operating cash flow to 334 million yuan, up 463.55% [2] Strategic Developments - The proprietary brand "Zhanjia" has been a key driver of growth, achieving a doubling of sales since its launch, with over 150% year-on-year growth in Q1 2025 [2][3] - The company has expanded its brand management partnerships, signing strategic agreements with international brands such as Amorepacific's "Meishanxuan" and DHC, enhancing its presence in the health and personal care sectors [3] - The agency operation business has seen significant improvements, with nearly 50 agency stores experiencing notable sales growth during the Double Eleven shopping festival, and several stores achieving double-digit increases in average transaction value [3] Future Outlook - For 2025, the company plans to continue building a multi-brand matrix focusing on personal care, household cleaning, and health sectors, positioning proprietary brands as a core competitive advantage [3] - The company aims to deepen its ecosystem across the supply chain and enhance vertical integration capabilities, while also developing standardized capabilities from demand insight to user conversion [3]

Core Insights - The company reported significant growth in both revenue and profit for the fiscal year 2024, with total revenue reaching 1.766 billion yuan, a year-on-year increase of 29.26%, and net profit attributable to shareholders at 106 million yuan, up 94.58% [1] - In Q1 2025, the company continued its growth trajectory, achieving revenue of 574 million yuan, a 54.16% increase year-on-year, and a net profit of 27.42 million yuan, up 113.88% [1] Business Performance - The company's self-owned brand business generated revenue of 501 million yuan in 2024, marking a 90.28% increase and accounting for 28.37% of total revenue [1] - The brand "Zhanjia" has shown exceptional growth, with its total sales doubling year-on-year across multiple channels, including Tmall, Douyin, and Xiaohongshu, with GMV growth exceeding 100% [1] - The newly launched health brand "FineNutri" has rapidly gained traction, ranking second in Tmall's oral beauty nutrition category and first in the health supplement store heat ranking as of March 2025 [2] Strategic Partnerships and Initiatives - The company signed strategic cooperation agreements with several international brands, including Amorepacific's "Meishangxuan" and DHC, to enhance its presence in the health and personal care sectors [3] - The company has also partnered with Norwegian company ZoocaCalanus for exclusive distribution of a key ingredient in Greater China and established a strategic investment collaboration with AI ingredient development firm MetaNovas [2] Operational Efficiency - The company's agency operation business generated revenue of 764 million yuan in 2024, with an overall gross margin improvement of nearly 5 percentage points compared to the previous year [3] - During the Double Eleven shopping festival, nearly 50 agency-operated stores saw significant GMV growth, with multiple partner stores ranking in the top 5 of their categories [3] Market Performance - The company's stock has been well-received in the market, closing at 51.4 yuan per share on April 24, 2024, reflecting a 5.7% increase, and a year-to-date gain of over 84%, bringing its total market capitalization to 8.4 billion yuan [3]

Core Viewpoint - The company Ruyuchen announced its 2024 annual distribution plan, proposing a 10-for-4 stock split and a cash dividend of 5 yuan (including tax), with a total cash distribution amounting to 79.32 million yuan, representing 75.09% of its net profit, resulting in a dividend yield of 2.92% based on the average trading price for the year [2][3]. Company Distribution History - The company has implemented its distribution plan five times since its listing, with the latest plan being a 10-for-4 stock split and a cash dividend of 5 yuan, totaling 79.32 million yuan and a dividend yield of 2.92% [2][3]. - Previous distribution plans include: - 2023: 10-for-4 stock split and a cash dividend of 3 yuan, totaling 34 million yuan, with a yield of 1.40% - 2022: 10-for-2.5 stock split and a cash dividend of 2.5 yuan, totaling 30 million yuan, with a yield of 1.39% - 2021: 10-for-2 stock split and a cash dividend of 2 yuan, totaling 24 million yuan, with a yield of 0.72% - 2020: 10-for-0.8 stock split and a cash dividend of 0.8 yuan, totaling 10 million yuan, with a yield of 0.18% [3]. Financial Performance - For the 2024 fiscal year, the company reported a revenue of 1.766 billion yuan, reflecting a year-on-year growth of 29.26% - The net profit reached 106 million yuan, marking a significant increase of 94.58% - Basic earnings per share were reported at 0.65 yuan, with a weighted average return on equity of 9.62% [3]. Market Activity - The stock experienced a net inflow of 25.86 million yuan from major funds on the day of the announcement, with a total net inflow of 23.31 million yuan over the past five days [4]. - In the broader context of the retail industry, 45 companies have announced their 2024 distribution plans, with China Duty Free Group leading with a cash distribution of 2.172 billion yuan [4].

Financial Performance - The company reported a basic earnings per share of 0.6500 yuan for 2024, a 96.97% increase compared to 0.3300 yuan in 2023 [1] - The total revenue for 2024 was 17.66 billion yuan, reflecting a 29.28% increase from 13.66 billion yuan in 2023 [1] - The net profit for 2024 reached 1.06 billion yuan, up 96.3% from 0.54 billion yuan in 2023 [1] - The return on equity (ROE) improved to 9.62% in 2024, a significant increase of 92.02% from 5.01% in 2023 [1] - The net asset per share decreased by 24.97% to 6.73 yuan in 2024 from 8.97 yuan in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 58.01 million shares, accounting for 47.98% of the circulating shares, with an increase of 6.2039 million shares compared to the previous period [1] - Notable shareholders include Langzi Co., Ltd. holding 1,637.03 million shares (13.54%), and Tianjin Yayi Biotechnology holding 1,344.00 million shares (11.11%) [2] - New entrants among the top shareholders include Xingquan Commercial Model Mixed Fund A with 500.74 million shares (4.14%) and Xingquan New Vision Fund with 259.78 million shares (2.15%) [2] Dividend Distribution - The company announced a dividend distribution plan of 10 shares for every 4 shares held, along with a cash dividend of 5 yuan (including tax) [4]

证券代码：003010 证券简称：若羽臣 公告编号：2025-038 广州若羽臣科技股份有限公司 关于增加公司经营场所及修订《公司章程》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 广州若羽臣科技股份有限公司（以下简称"公司"）于 2025 年 4 月 23 日召 开了第四届董事会第七次会议及第四届监事会第四次会议，审议通过了《关于增 加公司经营场所及修订<公司章程>的议案》，具体内容公告如下： 一、增加经营场所情况 为满足公司经营发展需要，结合当前实际情况，公司拟增加以下经营场所， 具体地址为广州市海珠区鼎新路 8 号 3801 室 3802 室 3803 室 3804 室 3805 室 3806 室。 二、修订《公司章程》的情况 鉴于公司拟增加经营场所的相关情况，同时依据《中华人民共和国公司 法》《上市公司章程指引》等法律法规及规范性文件的规定，结合公司实际， 公司拟对《广州若羽臣科技股份有限公司章程》（以下简称"《公司章程》"） 的部分条款进行修订，具体如下： | 原《公司章程》内容 | 修订后《公司章程》内容 | | --- | --- | ...

广州若羽臣科技股份有限公司 2024 年度董事会工作报告 2024 年，广州若羽臣科技股份有限公司（以下简称"公司"）董事会依照 《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易所股票上 市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》等法律法规、规范性文件及《广州若羽臣科技股份有限公司章程》等公司 相关制度的规定，本着恪尽职守、勤勉尽责的工作态度，依法独立行使职权，全 力保障股东权益、公司利益和员工的合法权益不受侵犯。切实履行股东大会赋予 的董事会职责，严格执行股东大会各项决议，勤勉尽责地开展各项工作，积极推 进董事会各项决议的实施，不断规范公司法人治理结构，确保董事会科学决策和 规范运作。现将 2024 年度董事会工作报告汇报如下： 一、公司总体经营情况 2024 年，公司持续聚焦品牌管理、自有品牌以及代运营业务，通过全链路、 全渠道的数字化能力赋能品牌生意健康增长，业绩增势显著。 2024 年，公司实现营业收入 17.66 亿元，同比增长 29.26%，其中归属于上 市公司股东的净利润为 1.06 亿元，同比增长 94.58%，归属于上市公司股东的扣 非净 ...